This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Melsha, C. Search for Related Content PubMed Articles by Melsha, C.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:799.)
© 2008 American Heart Association, Inc.

Editorials

Recipients of the 2008 New Investigator Awards

Connie Melsha

An extract of the first 250 words of the full text is provided, because this article has no abstract.

This is the third year of competition for ATVB New Investigator Awards. The Awards recognize papers published in ATVB in 2007 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling. We would like to point out that there are two award winners for the Dr Daniel Steinberg Award in Atherosclerosis/Lipoproteins for 2008. Both winners published similar findings related to the use of vaccination against the VEGF receptor 2 in attenuating the progression of atherosclerosis. These studies may have potential applications in the treatment of atherosclerosis.

In the third year of the award, 550 papers were submitted for the Awards. Recipients of the awards are:

Suzanne J.A. Korporaal, MD, University Medical Center Utrecht, the 2008 recipient of the Karl Link New Investigator Award in Thrombosis, for her . . . [Full Text of this Article]